BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Covid'. (Return)

CNBC FinanceOct 26, 2020
Stock futures rise slightly after market sell-off amid uptick in Covid cases
On Monday, equities plunged in their worst session since September amid a surge in Covid-19 cases across the country.

Forbes HeadlinesOct 26, 2020
Stimulus Negotiations Stall Over Covid-19 Testing Plan As Cases Surge To Record Highs
House Speaker Nancy Pelosi said Monday that the White House "refuses" to accept the Democrats' national testing and tracing plan.

Google Business NewsOct 26, 2020
Dow Jones Futures: Stock Market Rally Struggles As Coronavirus Cases Soar; Dexcom, Twilio Key Movers Late - Investor's Business Daily
Dow Jones Futures: Stock Market Rally Struggles As Coronavirus Cases Soar; Dexcom, Twilio Key Movers Late  Investor's Business DailyDow drops 650 points as S&P 500, Nasdaq post worst day since September  Fox BusinessStocks tumble as Covid-19 cases surge and stimulus is nowhere to be found  CNNWall Street Lower on Virus Surge, Stimulus Impasse; Dow Down 631 Pts  Investing.comStocks Slide on Coronavirus Uptick, Fading Stimulus Hopes  The Wall Street Journal

Forbes HeadlinesOct 26, 2020
Federal Government Will Set Up ‘Surge' Covid-19 Testing Sites In Four Additional States
The government deployed sites in Wisconsin and North Carolina last week.

RELATED ARTICLES
Market Snapshot: Dow ends 650 points lower as rising COVID-19 cases, stalled stimulus efforts highlight recovery jitters (MarketWatch)

USA Today MoneyOct 26, 2020
Dow drops 650 points as coronavirus counts jump
Stocks careened Monday as a spike in COVID-19 cases raised concerns on Wall Street that more woes could be ahead for the still-fragile global economy.       

Google Business NewsOct 26, 2020
Meadows under fire as Trump chief of staff for handling of pandemic and other crises - The Washington Post
Meadows under fire as Trump chief of staff for handling of pandemic and other crises  The Washington PostAs Trump says news about COVID should be illegal, WH chief of staff says goal is to 'defeat' virus, not 'control' it  Yahoo NewsWhite House sends mixed messages about controlling the coronavirus pandemic  CBS NewsSudden and Total Clarity About the 2020 Election  Bloomberg

RELATED ARTICLES
Coronavirus update: U.S. death toll tops 225,000 and Trump's chief of staff says U.S. is ‘not going to control the pandemic' (MarketWatch)

Yahoo BusinessOct 26, 2020
Good Entry Point for Gilead Sciences (GILD)? Not Just Yet, Says Analyst
Gilead Sciences (GILD) notched a first last week, when its antiviral coronavirus treatment Veklury (remdesivir) received full FDA approval.The treatment had previously been granted emergency use authorization (EUA), but the complete go ahead from the regulatory body makes it the first treatment to make it across the finish line.However, ultimately, Raymond James analyst Steven Seedhouse does not expect the long-awaited approval to have the impact investors might hope for."The formal FDA approval doesn't change our estimates or outlook for remdesivir, given it has already been branded standard-of-care prior to formal approval," Seedhouse said. "But the label and approval is pretty much a best case for GILD vs. what could have been post SOLIDARITY results. It remains unclear how frequently Veklury actually gets used going forward. Especially given the myriad post marketing requirements including requirement to more rigorously look at viral shedding and viral load in all samples collected and submit to FDA (which we suspect will show limited or no effect and thus offer no mechanistic support)."Gilead stock has been on a roller coaster ride in 2020. Shares rose dramatically following the pandemic's onset, as hopes were pinned on remdesivir to play its part in the battle against COVID-19.However, questions about the drug's commercial potential and contradicting clinical results, amongst other issues, have sent the share price on a downward trajectory since April's yearly peak.Earlier this month,

Forbes HeadlinesOct 26, 2020
New Jersey And Massachusetts Grapple With Covid Uptick As Cases Reach Highest Levels Since May
New Jersey and Massachusetts are dealing with more coronavirus cases than at any other point in the last five months.

MarketWatchOct 26, 2020
NewsWatch: Dow down more than 700 points as rise in COVID-19 cases underlines risks to recovery
Stocks stumble Monday as the number of daily U.S. COVID-19 infections hit a record at the end of last week and a final agreement on a new round of aid to the economy remains elusive.

MarketWatch MarketPulseOct 26, 2020
Stocks end sharply lower as investors battered by COVID-19 case surge
U.S. stock-market benchmarks ended sharply lower on Monday, but off their intraday lows amid investors jitters around rising COVID-19 cases in the U.S. and Europe. The S&P 500 fell 64 points, or 1.9%, to finish around 3,401. The Dow Jones Industrial Average slipped 650 points, or 2.3%, to end near 27,686, based on preliminary numbers. The Nasdaq Composite slumped 189 points, or 1.6%, to close around 11,359. Spain and Italy imposed new restrictions to limit the spread of the coronavirus, reviving concerns policymakers may institute lockdown measures. On the earnings front, Germany-based software giant SAP SE SAP , issued a profit and sales warning, sending shares of business software companies lower. Shares of Oracle , Salesforce.com and Microsoft Corp. all lost ground.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



Yahoo BusinessOct 26, 2020
SAP Sends Warning for Software Earnings With Dire Forecast
(Bloomberg) -- Dire earnings results at SAP SE wiped out more than 35 billion euros ($41 billion) from the German software company's market value in a matter of minutes, sending a warning to tech investors about the health of the business software industry.In a surprise release late Sunday, SAP, one of Europe's largest tech companies, cut its revenue forecast for the full year and said it expected the fresh wave of Covid-19 lockdowns to hurt demand through the first half of 2021. The results caused shares to fall the most ever in a single day, according to data compiled by Bloomberg since 1989.SAP's collapse caused the wider tech market to drop, with Europe's Stoxx Technology index falling 7.6%, its biggest one-day loss since March. Shares of cloud-applications giant Salesforce.com Inc. fell 4.1% at 2:28 p.m. in New York. Oracle Corp. -- SAP's main rival -- dropped 3.9%."SAP is a bellwether stock for European technology and global software," said Citigroup Global Markets analyst Amit Harchandani. "They have an insight into Fortune 500 companies and when SAP tells you they see headwinds, there will be some truth to the fact that some of the customers are challenged and don't have the money to spend."For some investors, SAP's results have called into question the wider assumption that software companies will prosper during the pandemic, due to millions of employees working from home. Many of these companies, which deliver applications or services over the internet, have so far resisted the worst effects of

The Motley FoolOct 26, 2020
Dow Jones Plunges 700 Points as Cases of Coronavirus Surge; Apple Stock Called a Buy but Still Sinks
A serious winter wave of COVID-19 is looking more and more likely.

MarketWatch MarketPulseOct 26, 2020
: SAP U.S. stock drops more than 20% on cut outlook
U.S. shares of SAP SE SAP opened more than 20% lower Monday after the German business software company cut its outlook due to prolonged work-from-home measures from COVID-19. American depositary receipts of SAP were last down 23% at $115.25 following a close of $149.68 on Friday. On Sunday, SAP cut its profit and sales outlook as a weaker-than-expected recovery in business travel has hurt its Concur expense management service. Also, because of its move to cloud-based services, SAP said it expects "software licenses revenue to continue to trend lower from 2020 levels."

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



MarketWatch MarketPulseOct 26, 2020
GeoVax shares rise on NIH vaccine deal
Shares of GeoVax Labs Inc. were up 12.8% in trading on Monday after the company announced a patent and material licensing deal with the National Institutes of Health for COVID-19 vaccine development. As part of the agreement, the clinical-stage company said it will get access to patent rights in the virus' spike protein and has non-exclusive rights to develop a COVID-19 vaccine. No financial terms were disclosed. GeoVax said it has four COVID-19 vaccine candidates in development, though none have moved past preclinical studies into phased testing in humans. GeoVax's stock has tumbled 70.3% so far this year, compared with the S&P 500 is up 7.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



KiplingerOct 12, 2020
10 Best European Stocks for an Income-Rich Recovery
Leading wealth managers including BlackRock, Merrill Lynch and Putnam are advising their clients to invest in foreign stocks to take advantage of better values overseas. And the market's best European stocks are one such store of value-priced diversification.

U.S. stocks are closing on all-time highs yet again, and the S&P 500 is trading at nearly 23 times trailing 12-month earnings. Foreign stocks are a bargain by comparison, trading at a P/E of less than 18, according to Morningstar.

Value is just one of many arguments in favor of international investing. For years, wealth advisors have told clients to invest a portion of their funds overseas to diversify portfolios and mitigate risk.

This advice is particularly timely now given that some European countries are recovering more quickly from COVID-19 than the U.S. In addition to individual-country measures, the European Union passed an $880 billion stimulus package; the U.S. continues to argue about its own follow-up plan.

Economists also anticipate a bigger GDP recovery for Europe next year, with growth pegged as high as 6% versus sub-5% growth for the U.S. Another factor is the present weakness of the U.S. dollar, which makes European stocks and other foreign equities more attractive for U.S. investors.  

Here are 10 of the best European stocks you can buy right now. They offer a combination of growth prospects and value. Better still, many of them offer healthy dividend yields, and some are even members of the European Dividend Aristocrats.

SEE MORE 65 Best Dividend Stocks You Can Count On in 2020

TRENDING TAGS
StocksCases Surge Virus making biggest
Stockmarket cases Today futures Surge
Casescoronavirus Dow points Surge Record
Coronaviruscases Dow high points latest
COVID-19Cases Surge Dow points Testing
Dowpoints cases coronavirus Down record
marketStock cases futures Stocks Dow
hitCoronavirus cases record high stocks
AntIPO Group raise Jack Ma
EarningsCall Transcript Q3 Inc Beat

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC